Pyxis Oncology, Inc. (PYXS)
Pyxis Oncology has a market cap or net worth of $66.93 million. The enterprise value is -$45.89 million.
The last earnings date was Tuesday, November 7, 2023, after market close.
|Earnings Date||Nov 7, 2023|
Pyxis Oncology has 44.32 million shares outstanding. The number of shares has increased by 26.94% in one year.
|Shares Change (YoY)||+26.94%|
|Shares Change (QoQ)||+7.67%|
|Owned by Insiders (%)||30.93%|
|Owned by Institutions (%)||26.24%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.16.
|Debt / Equity||0.16|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -63.30% and return on invested capital (ROIC) is -64.18%.
|Return on Equity (ROE)||-63.30%|
|Return on Assets (ROA)||-49.90%|
|Return on Capital (ROIC)||-64.18%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.41M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +3.10% in the last 52 weeks. The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average.
|52-Week Price Change||+3.10%|
|50-Day Moving Average||1.72|
|200-Day Moving Average||2.47|
|Relative Strength Index (RSI)||41.67|
|Average Volume (30 Days)||124,473|
Short Selling Information
The latest short interest is 801,069, so 1.81% of the outstanding shares have been sold short.
|Short Previous Month||792,474|
|Short % of Shares Out||1.81%|
|Short % of Float||2.70%|
|Short Ratio (days to cover)||9.29|
|Earnings Per Share (EPS)||-$2.55|
The company has $134.44 million in cash and $21.62 million in debt, giving a net cash position of $112.82 million or $2.55 per share.
|Cash & Cash Equivalents||134.44M|
|Net Cash Per Share||$2.55|
|Equity / Book Value||137.95M|
|Book Value Per Share||3.11|
In the last 12 months, operating cash flow was -$72.84 million and capital expenditures -$8.58 million, giving a free cash flow of -$81.43 million.
|Operating Cash Flow||-72.84M|
|Free Cash Flow||-81.43M|
|FCF Per Share||-$1.97|
Dividends & Yields
Pyxis Oncology does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Pyxis Oncology is $12.00, which is 694.70% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||694.70%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||-5.83%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|